Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether S-1 in combination with Cisplatin is
effective as 1st line therapy in slowing tumor activity in patients with advanced non-small
cell lung cancer. The study is also looking at the safety of S-1.
Phase:
Phase 2
Details
Lead Sponsor:
Taiho Oncology, Inc.
Collaborators:
Quintiles, Inc. United BioSource Corporation United BioSource, LLC